Novel N-sulfonamide trans-platinum complexes: synthesis, reactivity and in vitro evaluation

被引：23

作者：

Aleman, Jose ^{[1
]}

del Solar, Virginia ^{[2
]}

Alvarez-Valdes, Amparo ^{[2
]}

Rios-Luci, Carla ^{[3
]}

Padron, Jose M. ^{[3
]}

Navarro-Ranninger, Carmen ^{[2
]}

机构：

[1] Univ Autonoma Madrid, Dept Quim Organ C1, E-28049 Madrid, Spain

[2] Univ Autonoma Madrid, Dept Quim Inorgan C7, E-28049 Madrid, Spain

[3] Univ La Laguna, IUBO AG, San Cristobal la Laguna 38206, Spain

来源：

MEDCHEMCOMM | 2011年 / 2卷 / 08期

关键词：

METALLODRUG-PROTEIN INTERACTIONS; HEART CYTOCHROME-C; MASS-SPECTROMETRY; ANTICANCER; DRUGS; CISPLATIN; BIOMOLECULES; PHARMACOLOGY; MECHANISMS; INHIBITORS;

D O I：

10.1039/c1md00070e

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In this work, we described for the first time the synthesis of trans-N-sulfonamide platinum complexes. The antiproliferative activity (GI(50), mu M) of these new compounds in human solid tumors cells was compared to cisplatin.

引用

页码：789 / 793

页数：5

共 51 条

[1] New reactions of anticancer-platinum complexes and their intriguing behaviour under various experimental conditions
Aleman, Jose
del Solar, Virginia
Cubo, Leticia
Quiroga, Adoracion G.
Navarro Ranninger, Carmen
[J]. DALTON TRANSACTIONS, 2010, 39 (44) : 10601 - 10607
[2] Anticancer platinum complexes as non-innocent compounds for catalysis in aqueous media
Aleman, Jose
del Solar, Virginia
Navarro-Ranninger, Carmen
[J]. CHEMICAL COMMUNICATIONS, 2010, 46 (03) : 454 - 456
[3] Anand N., 1996, Burger's Medicinal Chemistry and Drug Discovery, V2, P527
[4] Synthesis and characterization of chiral platinum(II) sulfonamides:: (dppe)Pt(NN) and (dppe)Pt(NO) complexes
Becker, JJ
White, PS
Gagné, MR
[J]. INORGANIC CHEMISTRY, 1999, 38 (04) : 798 - 801
[5] HYDROLYSIS PRODUCTS OF CISPLATIN - PKA DETERMINATIONS VIA [H-1, N-15] NMR-SPECTROSCOPY
BERNERSPRICE, SJ
FRENKIEL, TA
FREY, U
RANFORD, JD
SADLER, PJ
[J]. JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1992, (10) : 789 - 791
[6] CONTROLLING PLATINUM, RUTHENIUM, AND OSMIUM REACTIVITY FOR ANTICANCER DRUG DESIGN
Bruijnincx, Pieter C. A.
Sadler, Peter J.
[J]. ADVANCES IN INORGANIC CHEMISTRY, VOL 61: METAL ION CONTROLLED REACTIVITY, 2009, 61 : 1 - 62
[7] Bruyninx M., 2008, CURR OPIN CHEM BIOL, V12, P197
[8] Biophysical characterisation of adducts formed between anticancer metallodrugs and selected proteins: New insights from X-ray diffraction and mass spectrometry studies
Casini, Angela
Guerri, Annalisa
Gabbiani, Chiara
Messori, Luigi
[J]. JOURNAL OF INORGANIC BIOCHEMISTRY, 2008, 102 (5-6) : 995 - 1006
[9] Insights into the molecular mechanisms of protein platination from a case study: The reaction of anticancer Platinum(II) iminoethers with horse heart cytochrome c
Casini, Angela
Gabbiani, Chiara
Mastrobuoni, Guido
Pellicani, Raffaella Zoe
Intini, Francesco Paolo
Arnesano, Fabio
Natile, Giovanni
Moneti, Gloriano
Francese, Simona
Messori, Luigi
[J]. BIOCHEMISTRY, 2007, 46 (43) : 12220 - 12230
[10] Exploring metallodrug-protein interactions by ESI mass spectrometry: The reaction of anticancer platinum drugs with horse heart cytochrome c
Casini, Angela
Gabbiani, Chiara
Mastrobuoni, Guido
Messori, Luigi
Moneti, Gloriano
Pieraccini, Giuseppe
[J]. CHEMMEDCHEM, 2006, 1 (04) : 413 - 417

← 1 2 3 4 5 6 →